Form 4: Charles River Laboratories International Director Sells Shar
Insider Transaction (Form 4)
Nancy C Andrews, a Director of Charles River Laboratories International, Inc., sold 573 shares of common stock on August 18, 2026 for $285.24 per share.
Summary
- Option exercise/conversion: acquired 573 Common Stock at $164.30 ($94,144) on August 18, 2026; holds 2,011 after (Direct).
- Open-market sale: disposed of 573 Common Stock at $285.24 ($163,443) on August 18, 2026; holds 1,438 after (Direct).
- Option exercise/conversion: disposed of 573 Stock Options (Right to Buy) on August 18, 2026 (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $163,443 of stock on the open market.
Insider Transactions
Nancy C Andrews — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-18 | Option exercise/conversion | Common Stock | 573 | $164 | $94.1K | 2,011 |
| 2026-08-18 | Open-market sale | Common Stock | 573 | $285 | $163.4K | 1,438 |
| 2026-08-18 | Option exercise/conversion | Stock Options (Right to Buy) | 573 | — | — | 0 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-18 | Option exercise/conversion (573 shares) |
| 2026-08-18 | Open-market sale (573 shares) |
| 2026-08-18 | Option exercise/conversion (573 shares) |
Keywords
insider transaction, Form 4, CRL, CHARLES RIVER LABORATORIES INTERNATIONAL, INC., bearish, Nancy C Andrews
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.